Allgens Medical Technology CO., LTD.

¥8.15As of Sun 8 Nov 2026, 12:00 UTC
SSE:688613Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (39.94%)
Div yield 0.37%
ROE 0.36%
Medical Devices
Beta (5Y) 0.67
PE TTM 133.1
TSR TTM (64.49%)
Mkt cap ¥1.117B
ROIC (0.69%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥9.21
13.05%
74.69%
Sell 1|10|10|4|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.11
0.12
0.12
0.12
19.59%
20.09%
22.41%
19.41%
Revenue¥M
50.14
49.85
49.82
50.72
3.04%
(1.31%)
1.47%
(0.70%)
Peers (US$167.4M)
Cap (US$)
PE
236.3M
17.21x
168.1M
14.20x
Capital
TTM
5Y
10Y
Leveragex
12.27
2.360
1.922
EBIT/Intx
17.06
0.155
0.211
Own earn%
112.58
(264.18)
(176.59)
Sh yield%
55.47
9.47
10.89
Owners
Insiders/Inst%
13.61
43.97
Short interest%
5.56
SBC / revenue%
2.22
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
2–4
$1 testx
0.4
Incr. ROIC%
1